Article ID Journal Published Year Pages File Type
6191546 European Journal of Surgical Oncology (EJSO) 2016 20 Pages PDF
Abstract
Neoadjuvant chemotherapy with mFOLFOX6 + bevacizumab was confirmed to increase the resectability of non-resectable liver metastases of colorectal cancer according to the independent assessments of surgeons.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Oncology
Preview
Evaluation of resectability after neoadjuvant chemotherapy for primary non-resectable colorectal liver metastases: A multicenter study
Authors
, , , , , , , , , , , , , , , ,